← Back to guidelines
Ophthalmology15 papers

Horner syndrome

Last edited: 4/14/2026

Overview

Horner syndrome is characterized by the clinical triad of miosis (pupillary constriction), ptosis (eyelid drooping), and anhidrosis (lack of sweating) on the affected side, resulting from disruption of the cervical sympathetic pathway. 46

Diagnosis

  • Key Diagnostic Criteria: Miosis, ptosis, anhidrosis.
  • Recommended Tests: Pharmacologic testing with apraclonidine 0.5% eye drops to confirm Horner syndrome by assessing reversal of anisocoria. 12
  • Grading: No standardized grading system mentioned; clinical presentation guides diagnosis.
  • Management

  • First-Line Treatments: Address underlying cause (e.g., tumor resection, trauma management).
  • Adjunctive Treatments: No specific pharmacological treatments for Horner syndrome itself; supportive care for symptoms.
  • Drug Classes/Doses: Apraclonidine 0.5% eye drops for diagnostic purposes only; caution in pediatric use due to potential systemic toxicity. 12
  • Special Populations

  • Pediatrics: Use of apraclonidine for diagnosis should be approached cautiously due to potential systemic side effects, though no adverse effects were reported in one study of 46 children. 21
  • Comorbidities: Management focuses on treating the underlying cause, particularly in cases involving neoplastic or traumatic origins. 4
  • Key Recommendations

  • Use apraclonidine 0.5% eye drops cautiously for diagnosing Horner syndrome in pediatric patients, monitoring closely for systemic side effects. (Evidence: Moderate 12)
  • In pediatric patients, consider alternative diagnostic methods if systemic toxicity concerns persist despite lack of reported adverse events in some cohorts. (Evidence: Expert opinion)
  • Promptly investigate and manage underlying causes of Horner syndrome, especially in pediatric cases where malignancy may be suspected. (Evidence: Moderate 4)
  • References

    1 Gish P, Kim I, Kapoor R, Jones SC. Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients. JAMA ophthalmology 2025. link 2 Eldib AA, Patil P, Nischal KK, Mitchell ER, Hiasat JG, Pihlblad MS. Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2021. link 3 Dafereras M, Sapouridis H, Laios K, Chrysikos D, Mavrommatis E, Troupis T. The pioneer ophthalmologist Johann Friedrich Horner (1831-1886) and the clinical anatomy of the homonymous syndrome. Acta chirurgica Belgica 2020. link 4 Folkert KN, de Beaufort H, Bauman NM. Horner Syndrome from a Pediatric Otolaryngology Perspective. The Annals of otology, rhinology, and laryngology 2020. link 5 Topcu-Yilmaz P, Kutluk S, Onder F. Horner Syndrome as a Rare Complication of Radiofrequency Tonsil Ablation. Journal of pediatric ophthalmology and strabismus 2018. link 6 Amonoo-Kuofi HS. Horner's syndrome revisited: with an update of the central pathway. Clinical anatomy (New York, N.Y.) 1999. link1098-2353(1999)12:5<345::AID-CA5>3.0.CO;2-L) 7 Gårde A. The man behind the syndrome: Friedrich Horner. Journal of the history of the neurosciences 1992. link 8 Parkinson D. Bernard, Mitchell, Horner syndrome and others?. Surgical neurology 1979. link

    Original source

    1. [1]
      Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients.Gish P, Kim I, Kapoor R, Jones SC JAMA ophthalmology (2025)
    2. [2]
      Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.Eldib AA, Patil P, Nischal KK, Mitchell ER, Hiasat JG, Pihlblad MS Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus (2021)
    3. [3]
      The pioneer ophthalmologist Johann Friedrich Horner (1831-1886) and the clinical anatomy of the homonymous syndrome.Dafereras M, Sapouridis H, Laios K, Chrysikos D, Mavrommatis E, Troupis T Acta chirurgica Belgica (2020)
    4. [4]
      Horner Syndrome from a Pediatric Otolaryngology Perspective.Folkert KN, de Beaufort H, Bauman NM The Annals of otology, rhinology, and laryngology (2020)
    5. [5]
      Horner Syndrome as a Rare Complication of Radiofrequency Tonsil Ablation.Topcu-Yilmaz P, Kutluk S, Onder F Journal of pediatric ophthalmology and strabismus (2018)
    6. [6]
      Horner's syndrome revisited: with an update of the central pathway.Amonoo-Kuofi HS Clinical anatomy (New York, N.Y.) (1999)
    7. [7]
      The man behind the syndrome: Friedrich Horner.Gårde A Journal of the history of the neurosciences (1992)
    8. [8]
      Bernard, Mitchell, Horner syndrome and others?Parkinson D Surgical neurology (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG